Venture Leaders Medtech 2024: 10 innovative startups selected for the Boston roadshow

The expert jury selected the 10 Venture Leaders Medtech 2024, who will travel to Boston from November 4th to 8th as part of the Swiss National Startup Team. The new Team is again a testament to Switzerland’s leadership in Medtech innovation. Venture Leaders Medtech is organized by Venturelab and Swissnex Boston and New York and supported by EPFL, ETH Zürich, Hansjörg Wyss, Health Innovation Hub Aargau, Kellerhals Carrard, Canton de Vaud, Canton Zurich, and Vischer.

The dedicated program will represent Swiss Medtech innovation in the United States for the fourth consecutive time. During the one-week roadshow, the 10 Venture Leaders will meet investors in the US and engage with executives and experts in the Medtech industry. “Preparing for this roadshow for the 18th year is a tribute to the quality of innovation and the startups that have been part of this journey,” shared Stefan Steiner, co-director partner of Venturelab. “I can’t wait to join this new edition and support the team in its international expansion.”

To select the 10 Venture Leaders Medtech 2024, a jury of professional investors and Medtech experts reviewed 60 applications. The 10 selected startups showcase an exceptional lineup of startups tackling global healthcare challenges across diverse areas such as increasing organ transplant availability, enhancing orthopaedic aftercare with implantable biosensors, improving fertility treatments, or leveraging AI to transform complex disease data into actionable insights for precision medicine."

Join the team’s introduction and online pitch session on September 18th, 2024, and discover the potential for innovation in the field of medical technology. 

Boston is one of the world’s major life sciences hubs and the ideal springboard for ambitious startups on their way to global expansion. By building a strong network, entrepreneurs will be able to accelerate their international growth. “Venture Leaders Medtech in Boston has unprecedentedly boosted our industrial and clinical contacts in the USA and helped me forge strong connections with fellow Swiss CEOs, as crucial to me as establishing business relations with future clients and partners,” highlighted Siew-Veena Sahi, CEO of Testmate Health, a Venture Leader Medtech 2023.

Follow the entrepreneurs and the Venture Leaders Medtech roadshow from November 4th to November 8th, 2024, on social media using the hashtag #VLeadersMedtech or on www.venture-leaders.ch/Medtech. 



About Venture Leaders
The Venture Leaders—the Swiss National Startup Team members—have a clear goal: They envision themselves as global players and want to take the first step toward their global expansion. Venturelab has 18 years of experience bringing Switzerland’s best entrepreneurs to the heart of the global technology hubs: Silicon Valley, Boston, China, London, Barcelona, and Munich. Companies founded by the 560 Venture Leaders alumni have created 11,900 jobs and raised more than CHF 8,3 billion in investment capital. For more information, visit www.venture-leaders.ch, and discover all the alumni here.

DISCOVER THE TEN 2024 VENTURE LEADERS MEDTECH:

Apersys: Overcoming organ shortage
Apersys is on a mission to save more patients in need of an organ transplant. Their perfusion platform technology paves the way for improving the number of transplantable organs and fostering translational research.

Metadvice: Accelerating Personalised and Complex Disease Care
Metadvice AI distills complex disease treatment and outcome data into actionable insights for clinicians and patients, assisting pharmaceutical companies with real-world evidence. The clinical knowledge engine sources data from a network of practitioners to take precision medicine to the next level

MYNERVA: Reduce pain and falls through AI-driven neurostimulation
MYNERVA has developed Leia, a groundbreaking medical device able to reduce falls and chronic pain in patients suffering from diabetic neuropathy through a combination of Artificial Intelligence and Non-invasive neurostimulation.